- Home
- NMRA vs CLPT Comparison
NMRA vs CLPT Comparison
Compare NMRA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | CLPT |
|---|---|---|
| Founded | 2019 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 494.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NMRA | CLPT |
|---|---|---|
| Price | $1.98 | $12.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $8.00 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 980.8K | 607.8K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $34,332,000.00 |
| Revenue This Year | N/A | $18.93 |
| Revenue Next Year | N/A | $51.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $0.61 | $9.76 |
| 52 Week High | $11.57 | $30.10 |
Technical Indicators
Market Signals| Indicator | NMRA | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 31.18 |
| Support Level | $2.05 | $13.00 |
| Resistance Level | $2.36 | $13.55 |
| Average True Range (ATR) | 0.14 | 0.71 |
| MACD | -0.04 | 0.13 |
| Stochastic Oscillator | 4.44 | 10.06 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.